<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18600" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Breast Fibroadenoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ajmal</surname>
            <given-names>Maleeha</given-names>
          </name>
          <aff>Allama Iqbal Med College, Jinnah Hosp</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khan</surname>
            <given-names>Myra</given-names>
          </name>
          <aff>University of Michigan</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Van Fossen</surname>
            <given-names>Kelly</given-names>
          </name>
          <aff>Cape Fear Valley Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Maleeha Ajmal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Myra Khan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kelly Van Fossen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18600.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>A breast fibroadenoma is a painless, unilateral, benign tumor that presents as a solid lump. It commonly occurs in women between the ages of 14 and 35. This activity illustrates the evaluation and management of breast fibroadenoma and highlights the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Assess the epidemiology of breast fibroadenoma.</p></list-item><list-item><p>Evaluate&#x000a0;the patient history associated with breast fibroadenoma.</p></list-item><list-item><p>Compare&#x000a0;the use of a breast mammogram and ultrasound in the evaluation of breast fibroadenoma.</p></list-item><list-item><p>Communicate&#x000a0;the importance of improving care coordination among the interprofessional team to improve patient outcomes with breast fibroadenomas.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18600&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18600">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-18600.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>A fibroadenoma is a painless, unilateral, benign (non-cancerous) breast tumor&#x000a0;that is a solid, not fluid-filled, lump. It occurs most commonly in women between 14 and 35 but can be found at any age. Fibroadenomas shrink after menopause and, therefore, are less common in post-menopausal women. Fibroadenomas are often referred to as&#x000a0;a 'breast mouse' due to their high mobility. Fibroadenomas&#x000a0;are a&#x000a0;marble-like mass&#x000a0;comprising both epithelial and stromal tissues located&#x000a0;under the skin of the breast. These&#x000a0;firm, rubbery masses with regular borders are often variable in size.</p>
      </sec>
      <sec id="article-18600.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The causes of fibroadenoma are debatable, but professionals&#x000a0;believe that&#x000a0;the lesion has a hormonal etiology related to the increased sensitivity of breast tissue to the female reproductive hormone estrogen. Fibroadenoma usually grows during pregnancy and tends to&#x000a0;shrink during menopause. This supports the hormonal etiologic theory. Females who take oral contraceptives before 20 years of age tend to&#x000a0;suffer from fibroadenoma at higher rates than the general population.</p>
      </sec>
      <sec id="article-18600.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Fibroadenoma tends to occur in early life. It is most commonly found in adolescents and less commonly in postmenopausal women. The incidence of fibroadenoma decreases with age and is generally found in females before 30 in the general population. It is&#x000a0;estimated that 10% of the world's female population suffers from fibroadenoma once in a lifetime.</p>
      </sec>
      <sec id="article-18600.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>
<bold>Hormonal</bold>
</p>
        <p>Fibroadenoma arises from stromal and epithelial connective tissue cells that are functionally and mechanically important in the breast. These tissues contain receptors for both estrogen and progesterone. For this reason, fibroadenomas&#x000a0;tend to&#x000a0;proliferate during pregnancy because of excessive production of female reproductive hormones. Hormone sensitivity causes excessive proliferation of breast connective tissues.</p>
        <p>
<bold>Genetics</bold>
</p>
        <p>Mediator complex subunit 12 (<italic toggle="yes">MED12</italic>) gene is also important in the pathophysiology of fibroadenomas.</p>
      </sec>
      <sec id="article-18600.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>A fibroadenoma is a well-circumscribed, non-encapsulated lesion with pushing borders that does not infiltrate the adjacent breast parenchyma. They are characterized by a cellular proliferation of stroma and glands (benign breast ducts). The ratio between stroma to glands is relatively constant throughout the entire lesion. The stroma is uniform, hypovascular, and composed of spindle-shaped cells with bland oval to elongated nuclei. There is no stromal cell pleomorphism present. Smooth muscle, cartilage, and bone&#x000a0;may be&#x000a0;identified in the stroma. Stromal mitosis,&#x000a0;although&#x000a0;rare, can be seen, especially in fibroadenomas&#x000a0;of&#x000a0;younger women, and does not indicate malignancy. In older women, the stroma can be hyalinized.</p>
        <p>The glands in a fibroadenoma consist of the normal bi-cell layer&#x000a0;in breast ducts. The inner glandular layer comprises cuboidal to columnar-shaped cells with uniform nuclei. The inner cell layer is&#x000a0;supported by an outer myoepithelial cell layer. The myoepithelial layer is intact throughout the entire lesion, designating a fibroadenoma's benign nature. Benign alterations&#x000a0;such as&#x000a0;usual ductal hyperplasia, apocrine metaplasia, squamous metaplasia, cystic changes, and sclerosing adenosis can involve the epithelium.&#x000a0;Calcifications can also be in the glands. In pregnancy, the&#x000a0;epithelium&#x000a0;may show lactation changes.&#x000a0;</p>
        <p>Fibroadenomas have&#x000a0;2 histological growth patterns: the intracanalicular pattern (see <bold>Image.</bold>&#x000a0;Fibroadenoma&#x000a0;With an Intracanalicular&#x000a0;Pattern) and the pericanalicular pattern. The stroma compresses and distorts the glands into cleft-like spaces in the intracanalicular pattern (see <bold>Image.</bold> Fibroadenoma With Proliferating Stroma Compressing Glands in the Breast).&#x000a0;The stroma surrounds the glands without distorting them, and the glands maintain their open lumens in the pericanalicular pattern (see <bold>Image.</bold> Fibroadenoma With Pericanalicular Pattern).&#x000a0;</p>
        <p>Histological variants of fibroadenomas exist. A myxoid fibroadenoma has prominent blue-tinged myxoid changes in the stroma (see <bold>Image.</bold> Myxoid Fibroadenoma). Although uncommon, some patients with myxoid fibroadenomas can have&#x000a0;Carney complex (an autosomal dominant disorder characterized by endocrine tumors, myxomas, skin hyperpigmentation, and blue nevi, among others).<xref ref-type="bibr" rid="article-18600.r1">[1]</xref> A cellular fibroadenoma has more stromal cellularity than usual. In a juvenile fibroadenoma, there is an increase in stromal cellularity and a greater degree of epithelial hyperplasia, commonly seen in young girls and adolescents. A complex fibroadenoma has sclerosing adenosis, epithelial calcifications, or papillary apocrine changes and is greater than 3 mm in size.<xref ref-type="bibr" rid="article-18600.r2">[2]</xref></p>
        <p>Despite the patterns and histological variants of fibroadenomas, this does not change the benign nature of the lesion. Rarely, atypical ductal hyperplasia, atypical lobular hyperplasia, ductal carcinoma in situ, lobular carcinoma in situ, and invasive carcinomas can involve a fibroadenoma. These patients are treated according to their high-risk, pre-cancer, or cancerous lesions.<xref ref-type="bibr" rid="article-18600.r3">[3]</xref></p>
      </sec>
      <sec id="article-18600.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Age is the most important factor in the incidence of fibroadenoma. Therefore, when obtaining a medical history, age is the most important factor which should be considered. A family history of breast cancer is also significant. Female patients who have first-degree relatives with breast cancer should be monitored and observed more carefully for malignant features than patients without this family history. Fibroadenoma most commonly occurs in the upper outer quadrant of the breast. On physical examination, it has the following features:</p>
        <list list-type="bullet">
          <list-item>
            <p>Non-tender or painless</p>
          </list-item>
          <list-item>
            <p>Mobile</p>
          </list-item>
          <list-item>
            <p>Solitary</p>
          </list-item>
          <list-item>
            <p>Rapidly&#x000a0;growing solid lump with rubbery consistency and regular borders.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18600.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>After a&#x000a0;thorough history and physical examination, the following imaging modalities are used to diagnose fibroadenomas.</p>
        <p>
<bold>Diagnostic Mammogram</bold>
</p>
        <p>A mammogram uses X-rays&#x000a0;to evaluate the suspicious masses in women above 35 years of age. Fibroadenoma on a mammogram appears as a distinct area from other breast tissue, with smooth, round edges. See Figure 1. Mammographic features of fibroadenomas are variable from a well-circumscribed discrete oval mass hypodense or isodense&#x000a0;of breast glandular tissue to a mass with macro lobulation or partially obscured margins. Involuting fibroadenomas in older, typically postmenopausal patients may contain calcification, often producing the classic, coarse popcorn calcification appearance.</p>
        <p>
<bold>Breast Ultrasound</bold>
</p>
        <p>Ultrasound uses sound waves to detect the features of fibroadenomas in women younger than 35 years of age. Ultrasound easily differentiates solid from the cystic masses. On ultrasound, a fibroadenoma is typically seen as a well-circumscribed, round to ovoid, or macrolobulated mass with generally&#x000a0;uniform hypoechogenicity.<xref ref-type="bibr" rid="article-18600.r4">[4]</xref><xref ref-type="bibr" rid="article-18600.r5">[5]</xref>&#x000a0;If necessary,&#x000a0;a minimally invasive biopsy may be performed via a&#x000a0;core needle biopsy<xref ref-type="bibr" rid="article-18600.r6">[6]</xref><bold/></p>
      </sec>
      <sec id="article-18600.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>In the majority of cases, fibroadenomas need no treatment. They shrink and disappear over time, but if their size is large and they are compressing other breast tissues, they should be removed. Many females decide against the surgery because the lesions are harmless and involve no long-term risk of malignancy. Surgery also distorts the shape of a breast.</p>
        <p>
<bold>Surgery</bold>
</p>
        <p>Doctors might decide to&#x000a0;remove the fibroadenoma if it is massive and continues to increase in size. Indications for surgical intervention include rapid growth, size greater than 2 cm, and patient request. There are&#x000a0;2 surgical procedures used to remove a fibroadenoma:</p>
        <list list-type="order">
          <list-item>
            <p>Lumpectomy or excisional biopsy:&#x000a0;In this procedure, the surgeon removes the fibroadenoma and sends it to the laboratory for further evaluation.</p>
          </list-item>
          <list-item>
            <p>Cryoablation:&#x000a0;Surgeons use a cryoprobe to freeze and destroy the cellular structure of fibroadenoma. A core needle biopsy must be performed before cryoablation to confirm the fibroadenoma.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18600.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>THe differential diagnoses for breast fibroadenoma include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Breast cyst</p>
          </list-item>
          <list-item>
            <p>Breast carcinoma</p>
          </list-item>
          <list-item>
            <p>Phyllodes tumor</p>
          </list-item>
          <list-item>
            <p>Breast lymphoma</p>
          </list-item>
          <list-item>
            <p>Metastasis to the breast from another primary site</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18600.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of fibroadenoma is good because it is a benign mass that shrinks in size over time in most cases.</p>
      </sec>
      <sec id="article-18600.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Breast cancer risk may slightly increase in patients with a complex fibroadenoma. This type of&#x000a0;lesion may contain calcified breast tissue.</p>
      </sec>
      <sec id="article-18600.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional approach to fibroadenoma is recommended. The majority of breast lesions in young women are identified on an incidental breast exam either by the patient or the healthcare provider. Even though fibroadenomas are benign lesions, sometimes the histology may need to be confirmed. Healthcare workers should never assume that all firm, rubbery lesions are benign. If ever in doubt, get a radiologist or surgeon to perform a biopsy. Missing a malignant breast lesion in a young female can lead to poor outcomes.</p>
      </sec>
      <sec id="article-18600.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18600&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18600">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/womens-health/breast-fibroadenoma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=18600">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18600/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18600">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-18600.s15">
        <fig id="article-18600.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Myxoid Fibroadenoma. Myxoid fibroadenoma shows&#x000a0;compression of glands by a blue-tinged myxoid stroma (x10). Contributed by M Khan, DO</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="myxoid__FA__10x__" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-18600.s16">
        <fig id="article-18600.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Fibroadenoma With an Intracanalicular Pattern. In a fibroadenoma with an intracanalicular pattern, the proliferating stroma compresses and distorts ductal epithelium into clefts (x10). Contributed by M Khan, DO</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Fibroadenoma" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-18600.s17">
        <fig id="article-18600.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Fibroadenoma With Proliferating Stroma Compressing Glands in the Breast (x10). Contributed by M Khan, DO</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Fibroadenoma__high__power__image__" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-18600.s18">
        <fig id="article-18600.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Fibroadenoma With Pericanalicular Pattern. A fibroadenoma with the pericanalicular pattern has a stroma proliferating around the gland with open lumens. Contributed by MKhan, DO</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pericanalicular__pattern__FA__" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-18600.s19">
        <title>References</title>
        <ref id="article-18600.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lozada</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Burke</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Maguire</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pareja</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gularte-Merida</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Brogi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Weigelt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Reis-Filho</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Geyer</surname>
                <given-names>FC</given-names>
              </name>
            </person-group>
            <article-title>Myxoid fibroadenomas differ from conventional fibroadenomas: a hypothesis-generating study.</article-title>
            <source>Histopathology</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>71</volume>
            <issue>4</issue>
            <fpage>626</fpage>
            <page-range>626-634</page-range>
            <pub-id pub-id-type="pmid">28513873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18600.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krings</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bean</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YY</given-names>
              </name>
            </person-group>
            <article-title>Fibroepithelial lesions; The WHO spectrum.</article-title>
            <source>Semin Diagn Pathol</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>438</fpage>
            <page-range>438-452</page-range>
            <pub-id pub-id-type="pmid">28688536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18600.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feliciano</surname>
                <given-names>YZ</given-names>
              </name>
              <name>
                <surname>Freire</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Net</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yepes</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Ductal and lobular carcinoma in situ arising within an enlarging biopsy proven fibroadenoma.</article-title>
            <source>BMJ Case Rep</source>
            <year>2021</year>
            <month>Jan</month>
            <day>19</day>
            <volume>14</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">33468635</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18600.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woodard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schetter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Millington</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and imaging characteristics of a juvenile fibroadenoma in a 2-year-old patient: a case report.</article-title>
            <source>Radiol Case Rep</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <page-range>6-10</page-range>
            <pub-id pub-id-type="pmid">29487631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18600.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Namazi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Adibi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Haghighi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hashemi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>An Evaluation of Ultrasound Features of Breast Fibroadenoma.</article-title>
            <source>Adv Biomed Res</source>
            <year>2017</year>
            <volume>6</volume>
            <fpage>153</fpage>
            <pub-id pub-id-type="pmid">29285483</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18600.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neville</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Neill</surname>
                <given-names>CO</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Corrigan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Redmond</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Feeley</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>O'Connell</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Browne</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Is excision biopsy of fibroadenomas based solely on size criteria warranted?</article-title>
            <source>Breast J</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>981</fpage>
            <page-range>981-985</page-range>
            <pub-id pub-id-type="pmid">29802656</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
